The genitourinary oncology field needs integration of results from basic science, epidemiological studies, clinical and translational research to improve the current methods for diagnosis. MS-based metabolomics can be transformative for disease diagnosis and contribute to global health parity. Metabolite panels are promising to translate metabolomic findings into the clinics, changing the current diagnosis paradigm based on single biomarker analysis. This review article describes capabilities of the MS-based oncometabolomics field for improving kidney, prostate, and bladder cancer detection, early diagnosis, risk stratification, and outcome. Published works are critically discussed based on the study design; type and number of samples analy...
Introduction: Over the last decade, the improvement in molecular techniques and the acquisition of g...
<div><p>Bladder cancer (BCa) is a common malignancy worldwide and has a high probability of recurren...
Bladder cancer (BCa) is a common malignancy worldwide and has a high probability of recurrence after...
Bladder cancer has a high incidence and is marked by high morbidity and mortality. Early diagnosis i...
Background:. Research of biomarkers in genitourinary tumors goes along with the development of compl...
BACKGROUND: The metabolomic approaches for mining biomarkers of women's cancers based on gas chromat...
Previous studies have shown that metabolomics can be a useful tool to better understand the mechanis...
project LA/P/0140/2020 of the Associate Laboratory Institute for Health and Bioeconomy - i4HB.Genito...
Metabolomic analysis has proven to be a useful tool in biomarker discovery and the molecular classif...
Background: Research of biomarkers in genitourinary tumors goes along with the development of comple...
Prostate, bladder and kidney cancer are the three most common types of genitourinary cancer in the w...
Renal cell carcinoma (RCC) represent 2-3% of all cancers. Currently, there are no invasive screening...
Bladder cancer (BC) is the second most prevalent malignancy in the urinary system and is associated ...
Gynaecological cancers are the major cause of cancer-related deaths in Indian women. The poor progno...
Genitourinary malignancies are a diverse group of cancers with an ever expanding array of therapeuti...
Introduction: Over the last decade, the improvement in molecular techniques and the acquisition of g...
<div><p>Bladder cancer (BCa) is a common malignancy worldwide and has a high probability of recurren...
Bladder cancer (BCa) is a common malignancy worldwide and has a high probability of recurrence after...
Bladder cancer has a high incidence and is marked by high morbidity and mortality. Early diagnosis i...
Background:. Research of biomarkers in genitourinary tumors goes along with the development of compl...
BACKGROUND: The metabolomic approaches for mining biomarkers of women's cancers based on gas chromat...
Previous studies have shown that metabolomics can be a useful tool to better understand the mechanis...
project LA/P/0140/2020 of the Associate Laboratory Institute for Health and Bioeconomy - i4HB.Genito...
Metabolomic analysis has proven to be a useful tool in biomarker discovery and the molecular classif...
Background: Research of biomarkers in genitourinary tumors goes along with the development of comple...
Prostate, bladder and kidney cancer are the three most common types of genitourinary cancer in the w...
Renal cell carcinoma (RCC) represent 2-3% of all cancers. Currently, there are no invasive screening...
Bladder cancer (BC) is the second most prevalent malignancy in the urinary system and is associated ...
Gynaecological cancers are the major cause of cancer-related deaths in Indian women. The poor progno...
Genitourinary malignancies are a diverse group of cancers with an ever expanding array of therapeuti...
Introduction: Over the last decade, the improvement in molecular techniques and the acquisition of g...
<div><p>Bladder cancer (BCa) is a common malignancy worldwide and has a high probability of recurren...
Bladder cancer (BCa) is a common malignancy worldwide and has a high probability of recurrence after...